Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors.
Vlahovic G, Meadows KL, Uronis HE, Morse MA, Blobe GC, Riedel RF, Zafar SY, Alvarez-Secord A, Gockerman J, Starodub AN, Ready NE, Anderson EL, Bendell JC, Hurwitz HI. Vlahovic G, et al. Among authors: anderson el. Cancer Chemother Pharmacol. 2012 Jul;70(1):95-102. doi: 10.1007/s00280-012-1889-8. Epub 2012 May 26. Cancer Chemother Pharmacol. 2012. PMID: 22638798 Free PMC article. Clinical Trial.
Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma.
Rizzieri DA, Sand GJ, McGaughey D, Moore JO, DeCastro C, Chao NJ, Vredenburgh JJ, Gasparetto C, Long GD, Anderson E, Foster T, Toaso B, Adams D, Niedzwiecki D, Gockerman JP. Rizzieri DA, et al. Cancer. 2004 Jun 1;100(11):2408-14. doi: 10.1002/cncr.20245. Cancer. 2004. PMID: 15160345 Free article. Clinical Trial.
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma.
Rizzieri DA, Akabani G, Zalutsky MR, Coleman RE, Metzler SD, Bowsher JE, Toaso B, Anderson E, Lagoo A, Clayton S, Pegram CN, Moore JO, Gockerman JP, DeCastro C, Gasparetto C, Chao NJ, Bigner DD. Rizzieri DA, et al. Blood. 2004 Aug 1;104(3):642-8. doi: 10.1182/blood-2003-12-4264. Epub 2004 Apr 20. Blood. 2004. PMID: 15100153 Free article. Clinical Trial.
Correction to: Genetic Risk, Dysbiosis, and Treatment Stratification Using Host Genome and Gut Microbiome in Inflammatory Bowel Disease.
Moustafa A, Li W, Anderson EL, MWong EH, Dulai PS, Sandborn WJ, Biggs W, Yooseph S, Jones MB, Venter CJ, Nelson KE, Chang JT, Telenti A, Boland BS. Moustafa A, et al. Among authors: anderson el. Clin Transl Gastroenterol. 2024 Dec 1;15(12):e00796. doi: 10.14309/ctg.0000000000000796. Clin Transl Gastroenterol. 2024. PMID: 39656168 Free PMC article. No abstract available.
Optically powered FiWi system for B5G hybrid VLC/RF access networks.
Pinto FBF, Souza LC, Andrade TPV, Lima ES, Anderson EL, Portelinha FM Jr, Cerqueira S A Jr. Pinto FBF, et al. Among authors: anderson el. Opt Express. 2024 Aug 12;32(17):30518-30530. doi: 10.1364/OE.528619. Opt Express. 2024. PMID: 39573210 Free article.
The role of accelerometer-derived sleep traits on glycated haemoglobin and glucose levels: a Mendelian randomization study.
Liu J, Richmond RC, Anderson EL, Bowden J, Barry CS, Dashti HS, Daghlas IS, Lane JM, Kyle SD, Vetter C, Morrison CL, Jones SE, Wood AR, Frayling TM, Wright AK, Carr MJ, Anderson SG, Emsley RA, Ray DW, Weedon MN, Saxena R, Rutter MK, Lawlor DA. Liu J, et al. Among authors: anderson el. Sci Rep. 2024 Jun 28;14(1):14962. doi: 10.1038/s41598-024-58007-9. Sci Rep. 2024. PMID: 38942746 Free PMC article.
267 results